cover image
Tutti i datori di lavoro

Revolution Medicines

Dettagli

  • Numero di dipendenti
    100-500
About Revolution Medicines

Revolution Medicines is a late-stage clinical oncology company focused on developing novel targeted therapies for patients with RAS-addicted cancers. The company’s research and development pipeline includes RAS(ON) inhibitors designed to suppress various oncogenic variants of RAS proteins, with several candidates currently in clinical development.

Career Opportunities

Revolution Medicines offers a dynamic working environment where professionals can contribute to groundbreaking cancer therapies. The company values innovation and collaboration, providing opportunities for career growth and development.

  • Collaborative work culture
  • Focus on professional development
  • Commitment to patient-centered outcomes